COVID-19 infections are also affected by human ACE1 D/I polymorphism
- 14 April 2020
- journal article
- letter
- Published by Walter de Gruyter GmbH in cclm
- Vol. 58 (7), 1125-1126
- https://doi.org/10.1515/cclm-2020-0425
Abstract
Article COVID-19 infections are also affected by human ACE1 D/I polymorphism was published on 14 Apr 2020 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (, Ahead of Publication).Keywords
This publication has 8 references indexed in Scilit:
- Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2Science, 2020
- The host’s angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infectionsClinica Chimica Acta; International Journal of Clinical Chemistry, 2020
- Complement C3 and its polymorphism: biological and clinical consequencesPathology, 2014
- The geographic distribution of the ACE II genotype: a novel findingGenetics Research, 2007
- Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphismClinica Chimica Acta; International Journal of Clinical Chemistry, 2006
- Angiotensin-converting enzyme 2 in lung diseasesCurrent Opinion in Pharmacology, 2006
- A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation?Blood Cells, Molecules, and Diseases, 2003
- Biological and clinical significance of haptoglobin polymorphism in humansClinical Chemistry, 1996